Innoviva, Inc., 10% Owner at Armata Pharmaceuticals, Inc. (ARMP), bought 15,435,322 shares at $2.87 ($44.3M) on 2020-03-27, disclosed to the SEC on 2020-03-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.87 | 7,717,661 | $22.1M | 50.0% |
| 2 | $2.87 | 7,717,661 | $22.1M | 50.0% |
| Total | $2.87 avg | 15,435,322 | $44.3M | 100% |
| Filing → |
| ARMP | BUY | 2021-03-17 | $27.9M | — | Filing → |
| ETTX | BUY | 2020-09-01 | $25.0M | — | Filing → |
| ETTX | BUY | 2020-06-12 | $31.7M | — | Filing → |